Eminence Capital, LP Charles River Laboratories International, Inc. Transaction History
Eminence Capital, LP
- $6.62 Billion
- Q3 2024
A detailed history of Eminence Capital, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Eminence Capital, LP holds 1,003,472 shares of CRL stock, worth $189 Million. This represents 2.98% of its overall portfolio holdings.
Number of Shares
1,003,472Holding current value
$189 Million% of portfolio
2.98%Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$703 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$400 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...